Furthermore, the fact that asparagine can facilitate CD8+ T cell activation and their anti-tumor responses will bring up the challenge of using L-asparaginase or asparagine-restricted diet in cancer patients concurrent with immunotherapy. The gene discussed is ASPG; the disease is neoplasm.